Celcuity Ownership | Who Owns Celcuity?
Celcuity Ownership Summary
Celcuity is owned by 71.77% institutional investors, 13.21% insiders, and 15.02% retail investors. Baker bros. advisors lp is the largest institutional shareholder, holding 12.66% of CELC shares. Eventide Healthcare & Life Sciences I is the top mutual fund, with 3.34% of its assets in Celcuity shares.
CELC Ownership Benchmark
Type | Name | % Inst | % Insiders | % Retail |
---|---|---|---|---|
Stock | Celcuity | 71.77% | 13.21% | 15.02% |
Sector | Healthcare Stocks | 212.97% | 10.98% | -123.95% |
Industry | Biotech Stocks | 290.86% | 10.94% | -201.80% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
Holder | Shares | % Holding | Value |
---|---|---|---|
Baker bros. advisors lp | 5.45M | 12.66% | $72.76M |
Morgan stanley | 2.84M | 8.44% | $46.44M |
Bvf inc/il | 3.47M | 8.05% | $46.27M |
Soleus capital management | 3.01M | 7.00% | $40.21M |
Nea management company | 2.29M | 5.33% | $30.63M |
Blackrock funding, inc. /de | 2.07M | 4.81% | $27.64M |
Blackrock | 1.46M | 4.34% | $23.91M |
Vanguard group | 1.65M | 3.86% | $21.62M |
Perceptive advisors | 1.63M | 3.79% | $21.80M |
Eventide asset management | 1.39M | 3.23% | $18.55M |
Top Institutional Shareholders by % of Total Assets
Holder | Shares | % Assets | Value |
---|---|---|---|
Saturn v capital management | 1.19M | 6.41% | $15.83M |
Soleus capital management | 3.01M | 2.66% | $40.21M |
Nea management company | 2.29M | 2.31% | $30.63M |
Bvf inc/il | 3.47M | 1.65% | $46.27M |
Vivo capital | 610.50K | 0.83% | $8.15M |
Pfizer | 349.41K | 0.81% | $4.66M |
Perceptive advisors | 1.63M | 0.81% | $21.80M |
Baker bros. advisors lp | 5.45M | 0.71% | $72.76M |
Braidwell lp | 884.31K | 0.40% | $11.81M |
Eventide asset management | 1.39M | 0.33% | $18.55M |
Top Buyers
Holder | Shares | % Assets | Change |
---|---|---|---|
Baker bros. advisors lp | 5.45M | 0.71% | 1.19M |
Nea management company | 2.29M | 2.31% | 1.04M |
Morgan stanley | 2.84M | 0.00% | 486.12K |
Soleus capital management | 3.01M | 2.66% | 437.70K |
Blackrock | 1.46M | 0.00% | 347.70K |
Top Sellers
Holder | Shares | % Assets | Change |
---|---|---|---|
Samlyn capital | - | - | -1.25M |
Vr adviser | - | - | -970.00K |
Janus henderson group | - | - | -796.98K |
Perceptive advisors | 1.63M | 0.81% | -729.07K |
Commodore capital lp | - | - | -695.65K |
New Positions
Holder | Shares | % Assets | Change | Value |
---|---|---|---|---|
Hrt financial lp | 26.39K | 0.00% | 26.39K | $352.00K |
M securities | 17.85K | 0.04% | 17.85K | $224.00K |
Price t rowe associates inc /md/ | 12.72K | - | 12.72K | $167.00K |
Xtx topco | 12.63K | 0.01% | 12.63K | $168.58K |
Manufacturers life insurance company, the | 10.83K | 0.00% | 10.83K | $141.71K |
Sold Out
Holder | Change |
---|---|
National bank of canada /fi/ | -1.00 |
Nelson, van denburg & campbell wealth management group | -3.00 |
Capital performance advisors llp | -10.00 |
Coldstream capital management | -53.00 |
Srs capital advisors | -104.00 |
Institutional Ownership Trends
Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
---|---|---|---|---|---|---|---|---|---|---|
Mar 31, 2025 | 98 | -6.67% | 30,900,273 | 1.70% | 71 | 1.42% | 50 | -9.09% | 27 | -10.00% |
Dec 31, 2024 | 56 | -48.15% | 7,202,654 | -76.01% | 16 | 0.34% | 33 | -49.23% | 10 | -44.44% |
Sep 30, 2024 | 108 | 16.13% | 30,022,227 | 2.25% | 70 | 0.92% | 65 | 10.17% | 18 | -10.00% |
Jun 30, 2024 | 92 | 13.58% | 29,360,224 | 32.68% | 87 | 1.00% | 59 | 22.92% | 20 | 11.11% |
Mar 31, 2024 | 81 | 32.79% | 22,129,121 | 38.67% | 93 | 1.80% | 48 | 54.84% | 18 | 28.57% |
Top Mutual Funds Shareholders
Holder | Shares | % Holding | Change |
---|---|---|---|
Eventide Healthcare & Life Sciences I | 1.27M | 3.34% | - |
Vanguard Total Stock Mkt Idx Inv | 1.12M | 2.73% | 138.31K |
Vanguard US Total Market Shares ETF | 1.00M | 2.66% | - |
iShares Russell 2000 ETF | 693.29K | 1.69% | -13.13K |
Columbia Small Cap Value I | 523.74K | 1.38% | 208.46K |
Belfius Equities Cure C Cap | 402.28K | 0.98% | 138.71K |
SPDR® S&P Biotech ETF | 327.79K | 0.88% | -2.00K |
Fidelity Small Cap Index | 330.93K | 0.81% | -3.79K |
Vanguard Institutional Extnd Mkt Idx Tr | 302.08K | 0.74% | -136.13K |
Artisan Non-U.S. Small-Mid Growth Comp | 273.60K | 0.72% | -52.97K |
Recent Insider Transactions
Date | Name | Role | Activity | Value |
---|---|---|---|---|
Jul 28, 2025 | Dalvey David | - | Sell | $992.60K |
Jul 28, 2025 | Dalvey David | - | Sell | $744.45K |
Jul 28, 2025 | Dalvey David | - | Sell | $190.69K |
Jul 28, 2025 | Dalvey David | - | Sell | $139.17K |
Jul 28, 2025 | Dalvey David | - | Sell | $2.47M |
Insider Transactions Trends
Date | Buy | Sell |
---|---|---|
2025 Q3 | - | 7 |
2025 Q2 | - | - |
2025 Q1 | - | - |
2024 Q4 | - | 1 |
2024 Q3 | - | 1 |
CELC Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools